Schedule 13G ownership disclosure

Lexeo Therapeutics Inc

Security class unavailable · CUSIP: 52886X107

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,597,736
Percent of class
7.8600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006396
Form type
SC 13G
Filer
Adage Capital Management, L.P.
CIK
CIK 1535978
Filed
Nov 12, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub